HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
TMO
Thermo Fisher Scientific Inc
Healthcare Diagnostics & Research · Massachusetts, USA · Reports in usd
$605.69
Market Cap: $242.09B
Market Cap
$242.09B
Enterprise Val
$280.58B
P/E Ratio
34.75
P/B Ratio
4.60
Trailing PEG (1Y)
3.72
As Of
Sep 17, 2026

Overview & Key Metrics

Reporting period: Jun 27, 2026 · Q2 2026
Book Value$52.69B
Gross Margin40.70%
Profit Margin40.70%
Return on Equity13.33%
Return on Assets6.34%
Current Ratio1.55
Debt/Equity0.81
LT Debt/Equity0.74
Revenue Per Share32.27

Income Statement

Jun 27, 2026
Revenue$11.99B
Cost of Revenue$7.11B
Gross Profit$4.88B
R&D$364.0M
SG&A$2.33B
Operating Expenses$2.80B
Operating Income$2.09B
Interest Expense$401.0M
Tax Expense$167.0M
Net Income$1.74B
EPS (Basic)$4.68
EPS (Diluted)$4.68
EBIT$2.30B
EBITDA$3.12B
Consolidated Income$1.74B
Non-Controlling Interests$5.0M

Balance Sheet

Jun 27, 2026
Cash & Equivalents$4.06B
Accounts Receivable$9.45B
Inventory$5.63B
Current Assets$23.37B
LT Investments$0.00
Property, Plant & Equipment$10.76B
Intangibles$73.44B
Non-Current Assets$89.81B
Total Assets$113.17B
Accounts Payable$3.27B
Current Debt$3.37B
Current Liabilities$15.07B
LT Debt$39.18B
Non-Current Liabilities$45.42B
Total Liabilities$60.49B
Total Debt$42.55B
Retained Earnings$62.19B
Shareholder Equity$52.68B
Shares Outstanding371,621,465

Cash Flow Statement

Jun 27, 2026
Operating Cash Flow$2.13B
Investing Cash Flow$164.0M
Financing Cash Flow-$1.57B
CapEx-$446.0M
Free Cash Flow$1.68B
Depreciation & Amort.$817.0M
Stock-Based Comp$82.0M
Acquisitions / Disposals$0.00
Investment Activity-$18.0M
Debt Issued/Repaid-$389.0M
Equity Issued/Repaid-$1.00B
Dividends Paid-$175.0M
Net Change in Cash$817.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h